OUR PORTFOLIO
We are partnering with companies and entrepreneurs that are advancing frontiers in science and technology.
Epsilogen
Boston, MA
Epsilogen is a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer.
VITTORIA Biotherapeutics
Philadelphia, PA
Harnessing the unrealized potential of CD5 as a novel checkpoint for cell therapies.
Cartography Biosciences
San Francisco, CA
Cartography Biosciences is
pioneering new ways to map
cancer antigens and develop the
next generation of targeted
therapies.
Acesion Pharma
Copenhagen, Denmark
Acesion Pharma is developing a next generation antiarrhythmic drug that targets the SK channel to treat atrial fibrillation (A-fib) without causing significant extracardiac and cardiac related adverse events.
SHIRATRONICS
Minneapolis, MN
Transform the lives of those living with Chronic Migraine.
Ensho Therapeutics
New York, NY
Ensho Therapeutics is a clinical-stage biopharmaceutical
company focused on developing breakthrough oral therapies for
patients with inflammatory bowel disease.
Odyssey Therapeutics
Boston, MA
Odyssey is creating next generation precision medicines for patients with cancer and inflammatory diseases by targeting key signaling nodes that are critical drivers of disease.
Nuvig Therapeutics
Menlo Park, CA
Developing a first-in-class Fc fragment
immunomodulator to treat autoimmune diseases.
Alveus Therapeutics
Philadelphia, PA
Alveus Therapeutics is a clinical-stage biotech developing next-generation therapies for obesity and metabolic
diseases, engineered for durable efficacy, better tolerability, and lower treatment burden.